ALSO NOTED: EMA grants Nuvelo orphan drug designation; AlgoRx, Corgentech's pain drug show promise; and much more...

> Nuvelo has received an orphan drug designation from the European Medicines Agency for alfimeprase, a product Nuvelo hopes will treat peripheral arterial occlusion (PAO). The drug has already received orphan indication status from the FDA. Release

> AlgoRx and Corgentech have promising data from their phase III local anesthetic ALGRX 3268, a powder injection for pain. Release

> A study published in the New England Journal of Medicine found that the withdrawn MS drug Tysabri could be effective in treating Crohn's disease. Article

> The FDA has approved an IND for Santaris' RNA-silencing cancer drug. Release

> Acambis and Bharat Biotech have signed a deal to develop Acambis' ChimeriVax-JE, an experimental vaccine for Japanese encephalitis. Release

And Finally... A recent study show that Viagra may have another therapeutic use as a treatment for Raynaud's disease in both men and women. Article